Mounjaro is a subcutaneous injection, which means it should be injected into the fatty tissues just beneath the skin
The SURMOUNT-3 study, after an organized intensive lifestyle intervention of 12-week, is a randomized 72-week clinical trial where patients receive placebo or TZP at the maximally tolerated dose
Pills designed for daily use arrive regularly on a subscription plan
Contact your healthcare provider immediately if you experience: Signs of dehydration, including decreased urination, dark urine, extreme thirst, dizziness, or lightheadedness Blood in stools or black, tarry stools Severe abdominal pain or cramping that doesn't resolve Fever above 101F (38.3C) accompanying diarrhea Unintentional weight loss beyond expected therapeutic effects Persistent nausea and vomiting preventing adequate fluid intake Symptoms of pancreatitis, including severe upper abdominal pain radiating to the back Signs of gallbladder disease, such as right upper quadrant pain, fever, or yellowing of skin/eyes Symptoms of kidney problems, including reduced urine output, swelling, or confusion These warning signs may indicate complications requiring urgent evaluation